Identification and characterization of muscarinic receptors in cultured human pancreatic carcinoma cells

Martha S. Ackerman, William R Roeske, Richard J. Heck, Murray Korc

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Five human pancreatic carcinoma cell lines were screened for the presence of muscarinic cholinergic receptors (mAChRs), using [<sup>3</sup>H]7V-meth-ylscopolamine ([<sup>3</sup>H]NMS). T3M4 and COLO-357 cells exhibited specific, high-affinity binding to mAChRs. A small amount of [<sup>3</sup>H]NMS also bound in PANC-I and ASPC-I cells, but not in MIA PaCa-2 cells. Atropine, pirenzepine (PZ), and ll-[[2-[(diethylamino) methyl]-1-piperidinyl] acetyl]-5, ll-dihydro-6H-pyrido-[2, 3-b][l, 4] benzodiazepine-6-one (AF-DX 116) inhibited [3H]NMS binding and carbachol-mediated [3H]inositol monophosphate formation in both T3M4 and COLO-357 cells. The order of inhibition was: Atropine > PZ > AF-DX 116. Carbachol did not alter [3H]inositol monophosphate formation in the other cell lines. These findings suggest that the mAChRs expressed in some human pancreatic cancer cells exhibit the pharmacologic characteristics of a muscarinic receptor subtype with an intermediate affinity for PZ and a lower affinity for AF-DX 116 and are functionally coupled to activation of phospholipid hydrolysis.

Original languageEnglish (US)
Pages (from-to)1-2
Number of pages2
JournalPancreas
Volume4
Issue number3
StatePublished - 1989

Fingerprint

Muscarinic Receptors
Pirenzepine
Cholinergic Receptors
Carbachol
Inositol
Atropine
Cell Line
Benzodiazepines
Pancreatic Neoplasms
Phospholipids
Hydrolysis
Pancreatic Carcinoma
otenzepad

Keywords

  • Muscarinic receptors
  • Pancreatic carcinomas
  • Phospholipid hydrolysis

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Hepatology
  • Internal Medicine

Cite this

Identification and characterization of muscarinic receptors in cultured human pancreatic carcinoma cells. / Ackerman, Martha S.; Roeske, William R; Heck, Richard J.; Korc, Murray.

In: Pancreas, Vol. 4, No. 3, 1989, p. 1-2.

Research output: Contribution to journalArticle

Ackerman, Martha S. ; Roeske, William R ; Heck, Richard J. ; Korc, Murray. / Identification and characterization of muscarinic receptors in cultured human pancreatic carcinoma cells. In: Pancreas. 1989 ; Vol. 4, No. 3. pp. 1-2.
@article{741447f7c02049a78696cc74fa7f7086,
title = "Identification and characterization of muscarinic receptors in cultured human pancreatic carcinoma cells",
abstract = "Five human pancreatic carcinoma cell lines were screened for the presence of muscarinic cholinergic receptors (mAChRs), using [3H]7V-meth-ylscopolamine ([3H]NMS). T3M4 and COLO-357 cells exhibited specific, high-affinity binding to mAChRs. A small amount of [3H]NMS also bound in PANC-I and ASPC-I cells, but not in MIA PaCa-2 cells. Atropine, pirenzepine (PZ), and ll-[[2-[(diethylamino) methyl]-1-piperidinyl] acetyl]-5, ll-dihydro-6H-pyrido-[2, 3-b][l, 4] benzodiazepine-6-one (AF-DX 116) inhibited [3H]NMS binding and carbachol-mediated [3H]inositol monophosphate formation in both T3M4 and COLO-357 cells. The order of inhibition was: Atropine > PZ > AF-DX 116. Carbachol did not alter [3H]inositol monophosphate formation in the other cell lines. These findings suggest that the mAChRs expressed in some human pancreatic cancer cells exhibit the pharmacologic characteristics of a muscarinic receptor subtype with an intermediate affinity for PZ and a lower affinity for AF-DX 116 and are functionally coupled to activation of phospholipid hydrolysis.",
keywords = "Muscarinic receptors, Pancreatic carcinomas, Phospholipid hydrolysis",
author = "Ackerman, {Martha S.} and Roeske, {William R} and Heck, {Richard J.} and Murray Korc",
year = "1989",
language = "English (US)",
volume = "4",
pages = "1--2",
journal = "Pancreas",
issn = "0885-3177",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Identification and characterization of muscarinic receptors in cultured human pancreatic carcinoma cells

AU - Ackerman, Martha S.

AU - Roeske, William R

AU - Heck, Richard J.

AU - Korc, Murray

PY - 1989

Y1 - 1989

N2 - Five human pancreatic carcinoma cell lines were screened for the presence of muscarinic cholinergic receptors (mAChRs), using [3H]7V-meth-ylscopolamine ([3H]NMS). T3M4 and COLO-357 cells exhibited specific, high-affinity binding to mAChRs. A small amount of [3H]NMS also bound in PANC-I and ASPC-I cells, but not in MIA PaCa-2 cells. Atropine, pirenzepine (PZ), and ll-[[2-[(diethylamino) methyl]-1-piperidinyl] acetyl]-5, ll-dihydro-6H-pyrido-[2, 3-b][l, 4] benzodiazepine-6-one (AF-DX 116) inhibited [3H]NMS binding and carbachol-mediated [3H]inositol monophosphate formation in both T3M4 and COLO-357 cells. The order of inhibition was: Atropine > PZ > AF-DX 116. Carbachol did not alter [3H]inositol monophosphate formation in the other cell lines. These findings suggest that the mAChRs expressed in some human pancreatic cancer cells exhibit the pharmacologic characteristics of a muscarinic receptor subtype with an intermediate affinity for PZ and a lower affinity for AF-DX 116 and are functionally coupled to activation of phospholipid hydrolysis.

AB - Five human pancreatic carcinoma cell lines were screened for the presence of muscarinic cholinergic receptors (mAChRs), using [3H]7V-meth-ylscopolamine ([3H]NMS). T3M4 and COLO-357 cells exhibited specific, high-affinity binding to mAChRs. A small amount of [3H]NMS also bound in PANC-I and ASPC-I cells, but not in MIA PaCa-2 cells. Atropine, pirenzepine (PZ), and ll-[[2-[(diethylamino) methyl]-1-piperidinyl] acetyl]-5, ll-dihydro-6H-pyrido-[2, 3-b][l, 4] benzodiazepine-6-one (AF-DX 116) inhibited [3H]NMS binding and carbachol-mediated [3H]inositol monophosphate formation in both T3M4 and COLO-357 cells. The order of inhibition was: Atropine > PZ > AF-DX 116. Carbachol did not alter [3H]inositol monophosphate formation in the other cell lines. These findings suggest that the mAChRs expressed in some human pancreatic cancer cells exhibit the pharmacologic characteristics of a muscarinic receptor subtype with an intermediate affinity for PZ and a lower affinity for AF-DX 116 and are functionally coupled to activation of phospholipid hydrolysis.

KW - Muscarinic receptors

KW - Pancreatic carcinomas

KW - Phospholipid hydrolysis

UR - http://www.scopus.com/inward/record.url?scp=84934741466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84934741466&partnerID=8YFLogxK

M3 - Article

C2 - 2734280

AN - SCOPUS:84934741466

VL - 4

SP - 1

EP - 2

JO - Pancreas

JF - Pancreas

SN - 0885-3177

IS - 3

ER -